
Loading, please wait...

Loading, please wait...

Electronic health records (EHRs) are powerful tools for monitoring clinical outcomes in chronic diseases. However, a major challenge lies in how we define remission in long-term conditions across different data sources. A recent scoping review analyzed 91 studies to clarify these definitions. Consequently, this research provides a vital framework for clinicians and data experts to harmonize their research methods. This step is essential as digital health infrastructure expands globally.
The scoping review investigated 12 different chronic conditions to identify common themes. Specifically, researchers found that inflammatory bowel disease, type 2 diabetes, and depression received the most attention. Interestingly, definitions of remission varied significantly across these studies. While many utilized validated rating scales, others relied on biochemical markers or the cessation of pharmacological treatments. Therefore, this variation highlights the urgent need for standardized criteria to allow accurate cross-study comparisons. Furthermore, the study emphasized that using a combination of clinical codes and lab results improves accuracy.
For example, in type 2 diabetes, remission often requires stable HbA1c levels without glucose-lowering medication for at least three months. In contrast, psychiatric remission might focus on the complete absence of symptoms on a standardized rating scale. Moreover, the review suggests that clear EHR-based definitions will advance our understanding of disease trajectories. By adopting these proposed standards, healthcare systems can better monitor patient outcomes over the long term. As a result, clinicians can leverage digital records to track population health more effectively.
Standardized definitions allow researchers to compare patient outcomes across different healthcare settings. Specifically, the integration of clinical codes with pharmacy records offers a comprehensive view of disease status. This transition from fragmented data to unified metrics represents a significant step forward for chronic disease management. Consequently, future research will likely focus on validating these definitions across diverse global populations to ensure generalizability and clinical relevance.
Remission is typically defined using a combination of clinical diagnostic codes, biochemical markers (like HbA1c), validated rating scales, and the absence of specific symptoms or the cessation of treatments.
Standardization ensures that data from different studies and hospitals can be compared accurately. It also helps clinicians monitor patient progress more reliably using automated digital tools and enhances the quality of clinical research.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hounkpatin H et al. Understanding Remission of Long-Term Conditions Through Electronic Health Records: Scoping Review. J Med Internet Res. 2026 May 19. doi: 10.2196/80796. PMID: 42155140.
Riddell MC et al. Consensus Statement on the Definition of Type 2 Diabetes Remission. Diabetes Care. 2021;44(10):2438-2444.
Turner D et al. Consensus definitions of clinical remission in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2007;26(10):1425-1432.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A scoping review of 91 studies explores how Electronic Health Records (EHRs) define remission across 12 long-term conditions, emphasizing standardization....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today